Product Description
To build up a long and mutual business relationship with clients, we are engaged in offering Oncotaxel Injection. Doctors use it in the treatment of ovarian cancer, breast cancer and advanced non-small cell lung cancer. Our diligent agents source his drug from the reputed vendors of the market. The drug is also useful for the treatment of cancer of pancreas and AIDS related kaposis sarcoma. Clients can avail Oncotaxel Injection in different strength of dosages from us.
Features:
- Stops the growth of cancer cells
- Precise composition
- Extended shelf life
High-Efficacy Chemotherapy for Multiple CancersOncotaxel Injection, with docetaxel as its active ingredient, is a WHO essential medicine and recognized by major global health authorities. It is especially valuable for treating patients with various malignancies such as breast, lung, prostate, stomach, and head and neck cancers. The ready-to-use, single-dose vial ensures sterility and consistency, supporting reliable cancer management under professional care.
Clinical Administration and Safety MeasuresAdministered through intravenous infusion by healthcare professionals, Oncotaxel requires careful handling due to potential serious adverse effects like neutropenia and hypersensitivity. Pre-infusion blood count checks and adherence to contraindicationssuch as hypersensitivity to docetaxel/polysorbate 80are crucial. Both efficacy and safety are ensured by following recommended storage, dilution, and administration protocols.
FAQs of Oncotaxel Injection:
Q: How is Oncotaxel Injection administered?
A: Oncotaxel Injection is given through intravenous infusion by a trained healthcare professional in a clinical setting. The appropriate dose is diluted with either 5% dextrose solution or normal saline, following standard infusion guidelines, and administered using non-PVC IV infusion sets to ensure compatibility.
Q: What cancers are treated with Oncotaxel Injection?
A: Oncotaxel Injection is used for the treatment of several cancers, including breast cancer, non-small cell lung cancer, prostate cancer, stomach cancer, and cancers of the head and neck. Your doctor will determine if this therapy is suitable for your specific diagnosis.
Q: When should Oncotaxel Injection not be used?
A: Oncotaxel Injection should not be used in patients with a history of severe hypersensitivity to docetaxel or polysorbate 80, or in those with a neutrophil count less than 1,500/mm. It is also contraindicated in certain other medical situationsconsult your physician for personalized guidance.
Q: Where should Oncotaxel Injection be stored?
A: Oncotaxel Injection should be stored between 225C, protected from light, and must not be frozen. It should always be kept in its original glass vial, inside the protective box, to maintain its sterility and efficacy until use.
Q: What are the most common side effects of Oncotaxel Injection?
A: Common adverse reactions include neutropenia (a decrease in white blood cells), hypersensitivity reactions, fluid retention, hair loss (alopecia), and occasionally an ethanol-like odor due to the solutions formulation. Your care team will monitor you closely for these effects during treatment.
Q: What are the benefits of using a ready-to-use sterile glass vial for Oncotaxel?
A: The ready-to-use, single-dose glass vial format ensures consistent dosing and sterility, reducing preparation errors and limiting infection risks. Each vial is individually boxed, supporting safe handling, shipping, and storage, and facilitating accurate administration per patient.